Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion in Parkinson's Disease: Extended Real World Data with Outpatient Dose Titration

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.